£52k
−42%vs Nov 2024Active14558665Private limited companyLondon
AFI CLINICAL DEVELOPMENT LTD
B68/10001
Summary
AFI CLINICAL DEVELOPMENT LTD is an active private limited company (company number 14558665) incorporated on 28 December 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 November 2025, showing net assets of £52k and cash of £53k, with 1 employee on average. Net assets fell 42% on the prior period (£89k).
Peer position · net assets
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Key dates
- Incorporated
- 28 December 20223 yrs ago
- Next accounts due
- 30 August 2027in 312 days
- Confirmation statement due
- 11 January 2027in 81 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
04
Financials
£53k
−49%vs Nov 2024Not reported
1
No changevs Nov 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £52k | £53k | — | £2,305 | — | — | 1 |
| 30 November 2024 | £89k | £104k | — | £16k | — | — | 1 |
Current ratio23.04Comfortable
Cash per employee£53kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
68 / 100 · grade B
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £52,141 at 2025-11-30 |
| −8 | Net assets falling-41.6% vs prior period |
| +8 | Comfortable liquidityCurrent ratio 23.04 |
| +4 | Cash reservesCash £53,101 |
| +4 | Past first filingsIncorporated 2022-12-28 |
| 68 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Mr Ibrahim Adiguzel
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 312 days
- Confirmation statement duein 81 days
- Accounts period endNet assets £52k · small accounts
- Accounts period endNet assets £89k · small accounts
- Incorporated
08
Similar companies in London
- EARLY HEALTH LTDLondon · inc. Dec 2022
- CONCEIVABLE LIFE SCIENCES LIMITEDLondon · inc. Jan 2023
- DNAME-IT HOLDINGS LIMITEDLondon · inc. Dec 2022
- IXCHEL MEDICAL LTDLondon · inc. Dec 2022
- MICO BIO PHARMA LTDLondon · inc. Dec 2022
- BRANCHPOINT THERAPEUTICS LTDLondon · inc. Jan 2023
All companies incorporated on 28 December 2022 · in Dec 2022.
09
Reminders for AFI CLINICAL DEVELOPMENT LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.